Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

SCYNEXIS Reports Second Quarter 2025 Financial Results and Provides Corporate Update

JERSEY CITY, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-res...

Symbol: SCYX
21 days ago

FIEE Announces Fiscal 2025 First Half Unaudited Financial Results

First Half Revenue of $45,118 Prepaid subscription fees received from customers for our SaaS service were $1.5 Million. HONG KONG, Aug. 13, 2025 /PRNewswire/ -- FiEE, Inc. (NASDAQ:FIEE) ("FiEE" or ...

Symbol: FIEE
21 days ago

Contango Announces Record High $23.0 Million in Income from Operations and $15.9 Million in Net Income for the Quarter Ended June 30, 2025

FAIRBANKS, Alaska, Aug. 13, 2025 /PRNewswire/ - Contango ORE, Inc. ("Contango" or the "Company") (NYSE American: CTGO) announced today that it filed with the Securities and Exchange Commission its ...

Symbol: CTGO
21 days ago

MDU Resources Announces Appointments to the Board of Directors

BISMARCK, N.D., Aug. 13, 2025 /PRNewswire/ -- MDU Resources Group, Inc. (NYSE: MDU) today announced the election of Charles M. Kelley and Tammy J. Miller to its board of directors, effective Aug. 1...

Symbol: MDU
21 days ago

XWELL, Inc. to Report Second Quarter 2025 Results on Thursday, August 14, 2025

Webcast and Conference Call Scheduled for 5:00 PM ET Webcast and Conference Call Scheduled for 5:00 PM ET

Symbol: XWELL
21 days ago

Global Water Resources Reports Second Quarter 2025 Results

PHOENIX, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, reported results for the second quarter ended June 30, 2025....

Symbol: GWRS
21 days ago

Verastem Oncology Announces Late-Breaking Abstract from Partner GenFleet Therapeutics’ Study in China of GFH375 (VS-7375) in Advanced Non-Small Cell Lung Cancer at IASLC 2025 World Conference on Lung Cancer

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK-pathway-driven cancers, today announced positi...

Symbol: VSTM
21 days ago

NASDAQ: REPL: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Class Action Lawsuit Against Replimune Group, Inc.

RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Replim...

Symbol: REPL
21 days ago

Luxfer Appoints Stewart Watson to Board of Directors

RIVERSIDE, Calif.--(BUSINESS WIRE)--Luxfer Holdings PLC (NYSE: LXFR) (“Luxfer” or the “Company”), a global industrial company innovating niche applications of advanced materials, today announced th...

Symbol: LXFR
21 days ago